DATASET RE-READ 2026-11-2042 PROGRAMSNEXLIFE PRICES READ 2026-11-20EVERY FIGURE CARRIES ITS READ DATE
TopGLP1Providers.comverified price index
DATED PRICES

Henry Meds vs Remedy Meds: November 2026 prices compared

As of November 20, 2026, from each program’s own page: on compounded tirzepatide, only Remedy Meds prints a comparable month-to-month price, $399 per 28-day cycle; Henry Meds shows only no tirzepatide price, so no like-for-like comparison is possible.

Released · Last reviewed · how we verify

On compounded semaglutide, month to month and all-in, Henry Meds charges $297 a month and Remedy Meds $299 per 28-day cycle: $3,564 against $3,887 for a year, so Henry Meds costs $323 less over a year.

Henry Meds and Remedy Meds, measure by measure

Henry Meds and Remedy Meds side by side, from each program’s own page read November 20, 2026 (all-in: medication plus any required recurring fee, before tax)
MeasureHenry MedsRemedy Meds
Tirzepatide, month to month—$399 (per 28-day cycle)
Tirzepatide, lowest printed—$399 (4-week supply; $279 first month only)
Semaglutide, month to month$297 (per month)$299 (per 28-day cycle)
Semaglutide, lowest printed$197 (12 months paid in full, $2,364)$299 (4-week supply; $179 first month only)
Dose pricingpriced by dose or not statedsame price at every dose
Membership or program feenonenone
Computed score21.1 of 40 (position 11 of 27)24.3 of 40 (position 7 of 27)
FDA warning lettersnone listed716830 (2025-09-09)
November 20 readfirst-party read, changedfirst-party read

Strengths and limitations: which fits whom

Henry Meds prints a month-to-month price; confirm whether it changes with the dose before you rely on it for a year. Remedy Meds prints one price at every dose with no membership, so a dose increase does not change the bill. Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound or Wegovy; a licensed clinician decides whether either is appropriate for you.

What changed since August

The first version of this comparison used captures from August 5–10, 2026. The November 20 re-read replaces them; the August figures are kept below as history, dated.

What changed since the August 2026 capture (maintenance-dose all-in figure then; month-to-month all-in figure read November 20, 2026)
ProgramMedicationAugust 5–10, 2026November 20, 2026
Henry Medssemaglutide—$297
Remedy Medstirzepatide—$399
Remedy Medssemaglutide—$299

Regulatory record

FDA’s warning-letter index lists warning letter 716830 (dated September 9, 2025, subject “Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)”) to Remedy Meds; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding.

Check Henry Meds’s current prices ↗
Check Remedy Meds’s current prices ↗

Frequently asked

Which is cheaper, Henry Meds or Remedy Meds?

On compounded tirzepatide, only Remedy Meds prints a comparable month-to-month price, $399 per 28-day cycle; Henry Meds shows only no tirzepatide price, so no like-for-like comparison is possible. On compounded semaglutide, month to month and all-in, Henry Meds charges $297 a month and Remedy Meds $299 per 28-day cycle: $3,564 against $3,887 for a year, so Henry Meds costs $323 less over a year.

Do Henry Meds and Remedy Meds charge a membership fee?

Henry Meds: no membership fee; Remedy Meds: no membership fee. This site folds any required recurring fee into the all-in figures above, so the comparison already counts it.

Are Henry Meds and Remedy Meds medications FDA-approved?

Compounded tirzepatide and semaglutide from any telehealth program are not FDA-approved and are not the same products as Zepbound, Mounjaro, Wegovy or Ozempic. Brand medications sold through a manufacturer or a brand route are FDA-approved. Ask each program which pharmacy fills the prescription.

Henry Meds recordHenry Meds alternativesRemedy Meds recordRemedy Meds alternativesAll head-to-headsRankingsPrice database

Sources

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.